Daniel Barber
2020
In 2020, Daniel Barber earned a total compensation of $840.1K as Chief Operating Officer at Aquestive Therapeutics, a 30% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $279,774 |
|---|---|
| Option Awards | $126,800 |
| Salary | $410,000 |
| Other | $23,509 |
| Total | $840,083 |
Barber received $410K in salary, accounting for 49% of the total pay in 2020.
Barber also received $279.8K in non-equity incentive plan, $126.8K in option awards and $23.5K in other compensation.
Rankings
In 2020, Daniel Barber's compensation ranked 9,313th out of 13,090 executives tracked by ExecPay. In other words, Barber earned more than 28.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,313 out of 13,090 | 29th |
Division Manufacturing | 3,974 out of 5,624 | 29th |
Major group Chemicals And Allied Products | 1,614 out of 2,257 | 29th |
Industry group Drugs | 1,412 out of 1,957 | 28th |
Industry Pharmaceutical Preparations | 1,035 out of 1,462 | 29th |
Source: SEC filing on May 5, 2021.
Barber's colleagues
We found two more compensation records of executives who worked with Daniel Barber at Aquestive Therapeutics in 2020.
News
Aquestive Therapeutics CEO Daniel Barber's 2023 pay jumps 88% to $2.5M
April 26, 2024
Aquestive Therapeutics CEO Keith Kendall's 2021 pay jumps 59% to $2M
April 29, 2022
Aquestive Therapeutics CFO John Maxwell's 2020 pay jumps 24% to $1.3M
May 5, 2021
Aquestive Therapeutics CEO Keith Kendall's 2019 pay falls 67% to $2.6M
April 29, 2020